Mark Andrew White - 08 Apr 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
General Manager, Commercial Affairs
Signature
/s/ Martin Wilson, as attorney-in-fact for Mark Andrew White
Issuer symbol
RCKT
Transactions as of
08 Apr 2024
Net transactions value
-$308,763
Form type
4
Filing time
10 Apr 2024, 20:39:37 UTC
Previous filing
21 Feb 2024
Next filing
09 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $308,763 -12,532 -14% $24.64 75,226 08 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. RSUs vest one-third (1/3) upon the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following two years.

Remarks:

General Manager, Commercial Affairs